Immediate Impact
69 standout
Citing Papers
A robust deep learning framework for multiclass skin cancer classification
2025 Standout
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Works of Anup Amatya being referenced
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non–Small-Cell Lung Cancer
2023
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anup Amatya | 142 | 122 | 79 | 47 | 638 | |
| Ofir Harari | 141 | 58 | 78 | 33 | 664 | |
| Michael J. Zoratti | 99 | 87 | 43 | 37 | 709 | |
| Matteo Quartagno | 186 | 118 | 54 | 38 | 671 | |
| Mugdha Gokhale | 77 | 119 | 26 | 29 | 578 | |
| Sarah Goring | 64 | 139 | 26 | 34 | 559 | |
| Ellen C. Caniglia | 91 | 56 | 57 | 42 | 665 | |
| Chi–Rong Li | 53 | 152 | 89 | 32 | 676 | |
| Mary E. Ritchey | 66 | 88 | 30 | 31 | 528 | |
| Alexandre Vivot | 48 | 62 | 42 | 29 | 726 | |
| Perrine Créquit | 48 | 171 | 96 | 43 | 675 |
All Works
Login with ORCID to disown or claim papers
Loading papers...